Effect of Time Shift of Transcranial Direct Current Stimulation (tDCS) for Treatment of Acute Tinnitus
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The treatment for patients with acute tinnitus consists of Methylprednisolone and hyperbaric oxygen therapy. For this study transcranial direct current stimulation (tDCS) was added to the protocol. The purpose is to determine the effect of the time shift of tDCS. Two conditions will be compared: tDCS simultaneously with the hyperbaric oxygen therapy or tDCS 3 weeks after the start of the tinnitus. An audiological testing will be performed at the day of admission, after 3 weeks, 6 weeks and 12 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2012
CompletedFirst Submitted
Initial submission to the registry
June 21, 2013
CompletedFirst Posted
Study publicly available on registry
June 26, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2014
CompletedJune 26, 2013
June 1, 2013
2 years
June 21, 2013
June 25, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Improvement of tinnitus
Tinnitus Questionnaire, Visual Analog Scale, Beck Depression Index, Hyperacusis questionnaire
12 weeks
Secondary Outcomes (1)
Hearing
12 weeks
Study Arms (2)
tDCS simultaneously with hyperbaric oxygen therapy
ACTIVE COMPARATORtDCS 3 weeks after start tinnitus
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- age between 18 and 50 years
- presence of acute tinnitus or worsening of tinnitus caused by otogenic disease
- registration in UZA within 48 hours after start tinnitus
- VAS-score ≥ 4
- ability to understand and sign informed consent
You may not qualify if:
- history of epileptic seizures
- severe organic comorbidity
- psychiatric disorders or a history of psychiatric disorders with psychotic symptoms
- Pace maker
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University hospital of Antwerp
Edegem, Antwerp, 2650, Belgium
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Sarah Rabau
Study Record Dates
First Submitted
June 21, 2013
First Posted
June 26, 2013
Study Start
April 1, 2012
Primary Completion
April 1, 2014
Last Updated
June 26, 2013
Record last verified: 2013-06